Find out more about how The Lecture List works.
Coronavirus situation updateOur lecture organisers may or may not have had time to update their events with cancellation notices. Clearly social gatherings are to be avoided and that includes lectures. STAY AT HOME FOLKS, PLEASE. |
Find out what you can do to keep The Lecture List online
|
There are now 2.5 million people living with cancer in the UK and survival rates for many cancers have improved radically over the last 20 years. New and improved treatments have played a major role in this change, however, the role of radiotherapy is far less well understood than that of other treatments such as chemotherapy and surgery.
Surviving cancer does not always mean living well. As the number of people living with and beyond cancer continues to increase, we will need a greater focus on recovery. This includes recognising and reducing the impact of consequences of cancer and its treatment, such as the impact on bone and heart health and the risk of developing another cancer.
Professor Jane Maher
Professor Jane Maher has been a clinical oncologist for over 25 years, specialising in breast and advanced prostate cancer. She has been Macmillanâs Chief Medical Officer since 1999 and is a consultant clinical oncologist at Mount Vernon Cancer Centre. Jane has a particular interest in living with and beyond cancer and the late consequences of cancer treatment. She has advised national NHS bodies and is well known for working to link patient priorities and the voluntary sector. She has written more than 100 published articles and advises on cancer survivorship programmes in Europe and Canada.
Speaker(s): |
Professor Jane Maher | talks |
|
|
Date and Time: |
23 June 2016 at 6:00 pm |
Duration: | 1 hour |
|
|
Venue: |
The Royal College of Radiologists |
|
|
Tickets: |
FREE |
Available from: |
|
Additional Information: |
The lecture is free but spaces are limited. |
Register to tell a friend about this lecture.
If you would like to comment about this lecture, please register here.
Any ad revenue is entirely reinvested into the Lecture List's operating fund